Researchers from the University of Barcelona in Barcelona, Spain, have developed an ultrahigh-performance liquid chromatography tandem mass spectrometry (UHPLC–MS/MS) method to determine eight banned dyes in turmeric, curry, and chili products (1).
The use of dyes to improve the aesthetic qualities of food is a common practice in food industries, however, certain types of dyes have been banned because they have been deemed unsafe for human consumption. Dyes such as Sudan I-IV, Sudan Orange, Sudan Red 7B, Para Red, and Rhodamine B have been banned in many countries because they have been linked to genotoxic and carcinogenic properties. However, not all countries have implemented such regulations and the monitoring of imported food products for such compounds is therefore of great importance, requiring new sensitive methods.
In this study, the feasibility of electrospray ionization (ESI), atmospheric-pressure chemical ionization (APCI), and atmospheric pressure photoionization (APPI) for the ionization of the dye compounds was evaluated. The tandem mass spectrometry (MS/MS) fragmentation of dye compounds was evaluated and used to establish fragmentation pathways and common fragmentation behaviours, with the most significant, characteristic, and abundant product ions being selected for a UHPLC–MS/MS method targeting those compounds from the spice samples.
The study identified that out of the three atmospheric pressure ionization sources APCI performed the best, with matrix effect (ME) values ranging from 2 to 25%. Furthermore, the proposed method performed well, providing low method limits of detection (MLODs) (1–48 μg kg−1), good intra-day precision (RSD % < 15%), and accurate quantitation (relative error % < 15%).
Researchers went on to demonstrate the applicability of the method through the analysis of turmeric, curry, and chili product, with the results showing that the method was able to detect the compounds in the low μg kg−1 range.
Reference
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.